137O: Nivolumab in patients (pts) with advanced refractory squamous (SQ) non-small cell lung cancer (NSCLC): 2-year follow-up from CheckMate 063 and exploratory cytokine profling analyses
Lena, H, Rizvi, N A, Wolf, J, Cappuzzo, F, Zalcman, G, Baas, P, Mazieres, J, Farsaci, B, Blackwood-Chirchir, M A, Ramalingam, S
Published in Journal of thoracic oncology (01.04.2016)
Published in Journal of thoracic oncology (01.04.2016)
Get full text
Journal Article
137O Nivolumab in patients (pts) with advanced refractory squamous (SQ) non-small cell lung cancer (NSCLC): 2-year follow-up from CheckMate 063 and exploratory cytokine profiling analyses
Lena, H., Rizvi, N.A., Wolf, J., Cappuzzo, F., Zalcman, G., Baas, P., Mazieres, J., Farsaci, B., Blackwood-Chirchir, M.A., Ramalingam, S.
Published in Journal of thoracic oncology (01.04.2016)
Published in Journal of thoracic oncology (01.04.2016)
Get full text
Journal Article